文献速递免疫规划

初次接种2剂与3剂人乳头瘤病毒(HPV)疫苗后的免疫记忆应答

Term immune memory responses to human papillomavirus (HPV) vaccination following 2 versus 3 doses of HPV vaccine.
PubMed 文献 · Vaccine · 2025-02-05

研究对既往参加2剂或3剂HPV疫苗试验的受试者在数年后追加一剂9价HPV疫苗,比较记忆B细胞、浆母细胞和抗体GMT相对基线的变化。结果显示追加剂后浆母细胞、记忆B细胞和抗体水平均较基线显著升高(p<0.05),但2剂与3剂受试者间浆母细胞和记忆B细胞增幅无显著差异。

要点

  • 追加一剂9价HPV疫苗后,浆母细胞、记忆B细胞和抗体GMT均较基线显著升高(p<0.05)。
  • 2剂与3剂受试者追加剂后浆母细胞和记忆B细胞数量增幅无显著差异。
  • 2剂或3剂HPV疫苗接种者均观察到稳健免疫应答,组间无显著差异。

核心结论

  • 2剂或3剂HPV疫苗接种者追加一剂后均观察到稳健免疫应答,且两组间无显著差异。

研究设计与样本

  • 研究对象为既往参加两项比较2剂与3剂HPV疫苗试验的受试者,数年后追加一剂Gardasil®9(9vHPV),比较免疫应答幅度。
  • 两项试验分组包括:2D儿童0和6月龄接种(G1a);3D儿童入组时9-13岁(08-001)或9-14岁(V503-010)(G2);3D女性16-26岁(G3)。
  • V503-010另有2D儿童0和12月龄接种组(G1b)。
  • 比较追加剂后1个月HPV特异性记忆B细胞(Bmem)数量(每组N=6,两项研究相同)和1周浆母细胞(PB)数量(08-001每组N=6;V503-010:G1a N=12、G1b N=8、G2 N=6、G3 N=28)相对基线的变化。
  • 比较HPV特异性抗体几何平均滴度(GMT)相对基线的变化(N同PB)。

主要发现

  • 追加一剂疫苗后,受试者浆母细胞、记忆B细胞数量和抗体水平(GMT)较基线均显著升高(p<0.05)。
  • 接受2剂或3剂疫苗的受试者间,浆母细胞和记忆B细胞数量增幅无显著差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Human papillomavirus (HPV) vaccines provide excellent protection from infection and disease. The minimum number of doses needed for long-term protection and the potential need for boosters are areas of continuing interest. Studies on the durability of vaccines have focused on antibodies, fewer have analyzed memory immune cells that could provide protection even when antibody levels are low. In this study, subjects who had participated in one of two trials comparing two and three doses (2D, 3D), were given an additional vaccine dose (Gardasil®9, 9vHPV) several years after the initial vaccine doses, and the magnitude of immune responses were compared. Both trials had 2D children who received doses at 0 and 6 months (G1a), 3D children 9-13 (08-001) or 9-14 (V503-010) years old at enrollment in the original trial (G2) and 3D women (age 16-26) (G3). Trial V503-010 had a second 2D group of children vaccinated at 0 and 12 months (G1b). Changes in numbers of HPV specific memory B cells (Bmem) (N = 6 per group, both studies) at 1 month and plasmablasts (PB) (08-001: N = 6 per group, V503-010: G1a N = 12, G1b N = 8, G2 N = 6, G3 N = 28) at 1 week, relative to baseline at the additional dose, were compared among groups. Changes in the geometric mean titers (GMTs) of HPV specific antibodies relative to baseline were compared (N = same as PB). Statistically significant (p < 0.05) increases in the numbers of PB, Bmem and antibody levels (GMT) were seen among subjects receiving an extra vaccine dose relative to baseline. Increases in the number of PB and Bmem were not significantly different among subjects receiving two or three doses. Thus, robust immune responses were observed and did not differ significantly among subjects vaccinated with two or three doses.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Carter JJ, Smith RA, Scherer EM, et al. Term immune memory responses to human papillomavirus (HPV) vaccination following 2 versus 3 doses of HPV vaccine. Vaccine. 2025. PMID: 39914257. doi:10.1016/j.vaccine.2025.126817

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。